Raj Vuppalanchi

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

Naga Chalasani, Herbert L. Bonkovsky, Robert J. Fontana et al. · Gastroenterology · 2015 · 872 citations · Full text

Dilin Prospective Study, Hepatology, Medicine +10

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

Rohit Loomba, Mark L. Hartman, Eric Lawitz et al. · New England Journal of Medicine · 2024 · 611 citations

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

Mohammad Shadab Siddiqui, Raj Vuppalanchi, Mark L. Van Natta et al. · Clinical Gastroenterology and Hepatology · 2018 · 580 citations · Full text

Hepatology, Medical Imaging, Nonalcoholic Fatty Liver Disease +12

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9